TO HEADED PAPER
<Doctor>
<Practice>
<Street>
<City>
<Postcode>
<Date>
Dear Dr <GP name>,
Re: Name: ………………………………………………………………………………………………………………….
DoB: …………………………………… ……… Hospital No: ……………………………………………..
Trial number: ……………………………… Date Registered: …………………………………..
A randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of Idiopathic Intracranial Hypertension: the
IIH:WT Trial (MRI Test Run)
Your patient, named above, has agreed to take part in an MRI test run. This test run is a scan to validate the MRI sequences used in the IIH:WT trial, a randomised controlled trial comparing two methods of weight loss in the treatment of Idiopathic Intracranial Hypertension
(IIH).
Your patient will not receive any trial treatment.
The MRI Test Run sub-study participants will each undergo 2 MRI scans, at least 2 weeks apart. The results will then be used to help the research team standardise the MRI tests for all participants in the trial.
This MRI Test Run is not a diagnostic procedure, but if any abnormalities are found which require follow up participants will be contacted by phone and if necessary invited to return to discuss the findings. The researcher will use their clinical judgement to decide if they need to be referred to an appropriate service.
IIH:WT MRI Letter to GP, Version 1.3 11 th November 2014 ISRCTN40152829
Page 1 of 2

IIH:WT is being coordinated by the University of Birmingham Clinical Trials Unit (address below), and is being funded by a National Institute for Health Research fellowship (Ref: NIHR-
CS-011-028). The trial has been approved by Black Country Research Ethics Committee.
IIH:WT is sponsored by the University of Birmingham.
If you require any further information about the trial or if you see your patient during the course of the trial and want to discuss any aspect of their management, please do not hesitate to contact me on Tel: 0121 414 3713 .
Please file this letter in the patient’s notes. I would appreciate being notified if he/she is no longer one of your patients.
Yours sincerely,
Dr Alex Sinclair
Neuroscience Trials Office, Birmingham Clinical Trials Unit, College of Medical & Dental
Sciences, Public Health Building, University of Birmingham, Birmingham, B15 2TT.
Web address: www.birmingham.ac.uk/IIHWT
Email address: neuroscience@trials.bham.ac.uk
IIH:WT MRI Letter to GP, Version 1.3 11 th November 2014 ISRCTN40152829
Page 2 of 2